221 Development of abatacept- and adalimumab-specific predictive models of response to therapy in rheumatoid arthritis using data from a head-to-head study

221 Development of abatacept- and adalimumab-specific predictive models of response to therapy in rheumatoid arthritis using data from a head-to-head study

Bandyopadhyay, Somnath;Maldonado, Michael A;Ammar, Ron;Schiff, Michael;Weinblatt, Michael;Fleischmann, Roy;Connolly, Sean E;
rheumatology 2018 Vol. 57 pp. -
182
somnath2018rheumatology221 development

Abstract

Background: Highly effective, targeted DMARD therapies with different mechanisms of action are available for RA. Translating precision medicine into clinical pr

Keywords

Citation

ID: 116722
Ref Key: somnath2018rheumatology221 development
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
116722
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet